Skip to main content
Review

The interrelationship between diabetes mellitus and peripheral arterial disease

A systematic review

Published Online:https://doi.org/10.1024/0301-1526/a000925

Summary: This systematic review examined the interrelationship between concomitant diabetes mellitus (DM) and peripheral arterial disease (PAD). The objective was to determine differences in the prevalence as well as in the outcomes in diabetic vs. non-diabetic PAD patients. The current review followed a study protocol that was published online in German in 2017. The search included societal practice guidelines, consensus statements, systematic reviews, meta-analyses, and observational studies published from 2007 to 2020 reporting symptomatic PAD and concomitant DM in patients undergoing invasive open-surgical and endovascular revascularizations. German and English literature has been considered. Eligibility criteria were verified by three independent reviewers. Disagreement was resolved by discussion involving a fourth reviewer. 580 articles were identified. After exclusion of non-eligible studies, 61 papers from 30 countries remained, respectively 850,072 patients. The included studies showed that PAD prevalence differed between diabetic vs. non-diabetic populations (20–50% vs. 10–26%), and further by age, gender, ethnicity, duration of existing diabetes, and geographic region. The included studies revealed worse outcomes regarding perioperative complications, amputation rate, and mortality rate in diabetic patients when compared to non-diabetic patients. In both groups, the amputation rates decreased during the research period. This review emphasizes an interrelationship between PAD and DM. To improve the outcomes, early detection of PAD in diabetic patients, and vice versa, should be recommended. The results of this systematic review may help to update societal practice guidelines.

References

  • 1 Chang CH, Huang CC, Hsu H, et al. Editor’s Choice – Diabetic limb salvage with endovascular revascularisation and free tissue transfer: long-term follow up. Eur J Vasc Endovasc Surg. 2019;57:527–36. First citation in articleCrossref MedlineGoogle Scholar

  • 2 Ali RS, Ozdemir BA, Hinchliffe RJ. Critical appraisal of the quality of evidence addressing the diagnosis, prognosis, and management of peripheral artery disease in patients with diabetic foot ulceration. Eur J Vasc Endovasc Surg. 2018;56:401–8. First citation in articleCrossref MedlineGoogle Scholar

  • 3 IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019. First citation in articleGoogle Scholar

  • 4 Consentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2019;41:255–323. First citation in articleCrossrefGoogle Scholar

  • 5 Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, Donato G, et al. Chapter I: definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011;4–12. First citation in articleGoogle Scholar

  • 6 Kreutzburg T, Peters F, Rieß HC, Hischke S, Marschall U, Kriston L, et al. Editor’s choice – comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data. European J Vasc Endovasc Surg. 2020;59:59–66. First citation in articleCrossref MedlineGoogle Scholar

  • 7 Lawall H, Huppert P, Rümenapf G. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit (pAVK). DGA AWMF. 2015;1–135. First citation in articleLinkGoogle Scholar

  • 8 Aboyans V, Ricco JB, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T, et al. ESC guidelines of the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery. Eur Heart J. 2017;2018(39):763–821. First citation in articleGoogle Scholar

  • 9 Behrendt CA, Sigvant B, Szeberin Z, Beiles B, Eldrup N, Thomson IA, et al. International variations in amputation practice: A VASCUNET report. Eur J Vasc Endovasc Surg. 2018;56:391–99. First citation in articleCrossref MedlineGoogle Scholar

  • 10 Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of Cardiology/American heart association Task Force on clinical practice guidelines. Circulation. 2017;135:686–725. First citation in articleGoogle Scholar

  • 11 Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69:3–125. First citation in articleCrossrefGoogle Scholar

  • 12 Frank U, Nikol S, Bell J, Boc V, Brodman M, Carpentier PH. ESVM guideline on peripheral arterial disease. VASA. 2019;48:1–79. First citation in articleLinkGoogle Scholar

  • 13 Mahmoud N. Diabetes Mellitus und periphere arterielle Verschlusskrankheit – Ein systematisches Review. Universitätsklinikum Hamburg-Eppendorf, Editor. 2020;1–62. First citation in articleGoogle Scholar

  • 14 Moher D, Liberati A, Tetzlaff J, Altman DJ. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:1–8. First citation in articleCrossrefGoogle Scholar

  • 15 Cornejo Del Río V, Mostaza J, Lahoz C, Sanchez-Arroyo V, Sabin C, Lopez S, et al. Prevalence of peripheral artery disease (PAD) and factors associated: an epidemiological analysis from the population- based screening pre-diabetes and type 2 Diabetes (SPREDIA-2) study. PLoS One. 2017;12:1–17. First citation in articleCrossrefGoogle Scholar

  • 16 Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P, et al. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol. 2016;15:1–9. First citation in articleCrossref MedlineGoogle Scholar

  • 17 Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Williams B, Lisheng L, et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care. 2016;39:1796–803. First citation in articleCrossref MedlineGoogle Scholar

  • 18 Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds. 2011;10:152–66. First citation in articleCrossref MedlineGoogle Scholar

  • 19 Lazzarini PA, Hurn SE, Fernando ME, Jen SD, Kuys SS, Kamp MC, et al. Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis. BMJ Open. 2015;5:1–15. First citation in articleCrossrefGoogle Scholar

  • 20 Coce F, Metelko Z, Jaksic B, Car N, Pavkovic P. Peripheral arterial disease and Diabetes Mellitus. Diabetologia Croatica. 2008;37(2):47–53. First citation in articleGoogle Scholar

  • 21 Rhee SY, Guan H, Liu ZM, Cheng SWK, Waspadji S, Palmes P, et al. Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res Clin Pract. 2007;76:82–92. First citation in articleCrossref MedlineGoogle Scholar

  • 22 Tseng CH. Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients. Circ J. 2007;71:1131–6. First citation in articleCrossref MedlineGoogle Scholar

  • 23 Velescu A, Clara A, Peñafiel J, Grau M, Degano IR, Martin R, et al. Peripheral arterial disease incidence and associated risk factors in a mediterranean population-based cohort. Eur J Vasc Endovasc Surg. 2016;51:696–705. First citation in articleCrossref MedlineGoogle Scholar

  • 24 Eshcol J, Jebarani S, Anjana RM, Mohan V, Pradeepa R. Prevalence, incidence and progression of peripheral arterial disease in Asian Indian type 2 diabetic patients. J Diabetes Complications. 2014;28:627–31. First citation in articleCrossref MedlineGoogle Scholar

  • 25 Guerchet M, Aboyans V, Mbelesso P, Mouagana AM, Salazar J, Bandzouzi B, et al. Epidemiology of peripheral artery disease in elder general population of two cities of Central Africa: Bangui and Brazzaville. Eur J Vasc Endovasc Surg. 2012;44:164–9. First citation in articleCrossref MedlineGoogle Scholar

  • 26 Oyelade Bolaji O, Ola Olarun Akintayo D, Odeigah Louis O, et al. The prevalence of peripheral arterial disease in diabetic subjects in south-west Nigeria. Afr J of Prim Health Care Fam Med. 2012;4:1–6. First citation in articleGoogle Scholar

  • 27 Yakubu PD, Khanna NN, Bakari AG, Garko SB, Abubakar AB, Adeiza MA, et al. Assessment of predictors and prevalence of peripheral artery disease among type 2 diabetic patients in Zaria, Northern Nigeria. Int J Clin Cardiol Res. 2018;2:8–13. First citation in articleGoogle Scholar

  • 28 Tavinthran S, Cheung N, Lim SC, Tay W, Shankar A, Tai ES, et al. Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. Diab Vasc Dis Res. 2009;6:80–6. First citation in articleCrossref MedlineGoogle Scholar

  • 29 Rabia K, Khoo EM. Prevalence of peripheral arterial disease in patients with diabetes mellitus in a primary care setting. Med J Malaysia. 2007;62(2):130–3. First citation in articleMedlineGoogle Scholar

  • 30 Narayanan RML, Koh WP, Phang J, Subramaniam T. Peripheral arterial disease in community-based patients with diabetes in Singapore: results from a primary healthcare study. Ann Acad Med Singapore. 2010;39:525–31. First citation in articleMedlineGoogle Scholar

  • 31 Vitalis A, Lip GY, Kay M, Vohra RK, Shantsila A. Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2017;15:327–33. First citation in articleCrossref MedlineGoogle Scholar

  • 32 Matsushita K, Sang Y, Ning H, Ballew SH, Chow EK, Graw ME, et al. Lifetime risk of lower-extremity peripheral artery disease by ankle-brachial index in the United States. J Am Heart Assoc. 2019;8:1–9. First citation in articleCrossrefGoogle Scholar

  • 33 Behrendt CA, Bischoff MS, Schwaneberg T, Hohnhold R, Diener H, Debus ES, et al. Population based analysis of gender disparities in 23.715 percutaneous endovascular revascularisations in the metropolitan area of Hamburg. Eur J Vasc Endovasc Surg. 2019;57:658–65. First citation in articleCrossref MedlineGoogle Scholar

  • 34 Brechow A, Slesaczeck T, Münch D, Nanning T, Paetzold H, Schwanebeck U, et al. Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease. Ther Adv Endocrinol. 2013;4:83–94. First citation in articleCrossref MedlineGoogle Scholar

  • 35 Freisinger E, Malyar NM, Reinecke H, Lawall H. Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis. Cardiovasc Diabetol. 2017;16:1–10. First citation in articleCrossref MedlineGoogle Scholar

  • 36 Gazzaruso C, Coppola A, Collaviti S, Saluzzo CM, Furlani F, Gallotti P, et al. Percutaneous transluminal angioplasty for critical limb ischemia in very elderly diabetic patients. Aging Clin Exp Res. 2013;25:225–8. First citation in articleCrossref MedlineGoogle Scholar

  • 37 Gentile F, Lundberg G, Hultgren R. Outcome for endovascular and open procedures in infrapopliteral lesions for critical limb ischemia: registry based single center study. Eur J Vasc Endovasc Surg. 2016;52:643–49. First citation in articleCrossref MedlineGoogle Scholar

  • 38 Giugliano G, Perrino C, Schiano V, Brevetti L, Sannino A, Schiattarella GG, et al. Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. BMC Surg. 2012;12(Suppl 1):19. First citation in articleCrossref MedlineGoogle Scholar

  • 39 Hicks CW, Najafian A, Farber A, Menard TM, Malas MB, Black JH, et al. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia. J Vasc Surg. 2016;64:1667–74. First citation in articleCrossref MedlineGoogle Scholar

  • 40 Hinchliffe RJ, Andros G, Apelqvist J, Bakker K, Friederichs S, Lammer J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev. 2012;28:179–217. First citation in articleCrossref MedlineGoogle Scholar

  • 41 Janas AJ, Milewski KP, Buszman PP, Trendel W, Kolarczyk-Haczyk A, Hochul M, et al. Long-term outcomes in diabetic patients treated with atherectomy for peripheral artery disease. Card J. 2018;10:1–19. First citation in articleGoogle Scholar

  • 42 Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433–37. First citation in articleCrossref MedlineGoogle Scholar

  • 43 Lin JH, Brunson A, Romano PS, Mell MW, Humphries MD. Endovascular-first treatment is associated with improved amputation-free survival in patients with critical limb ischemia. Circ Cardiovasc Qual Outcomes. 2019;12:1–15. First citation in articleCrossrefGoogle Scholar

  • 44 Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia. 2008;51:747–55. First citation in articleCrossref MedlineGoogle Scholar

  • 45 Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson K-F, Apelqvist J. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg. 2014;48:440–6. First citation in articleCrossref MedlineGoogle Scholar

  • 46 Elgzyri T, Larsson J, Thörne J, Eriksson K-F, Apelqvist J. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg. 2013;46:110–7. First citation in articleCrossref MedlineGoogle Scholar

  • 47 Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, Kragsterman B, Johansson S, et al. Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study. Eur J Vasc Endovasc Surg. 2017;54:480–548. First citation in articleCrossref MedlineGoogle Scholar

  • 48 Rhee SY, Kim YS. Peripheral arterial disease in patients with type 2 diabetes mellitus. Diabetes Metab J. 2015;39:283–90. First citation in articleCrossref MedlineGoogle Scholar

  • 49 Escobar C, Blanes I, Ruiz A, Vinuesa D, Montero M, Rodriguez M. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J Int Med. 2011;22:275–81. First citation in articleCrossref MedlineGoogle Scholar

  • 50 Collins TC, Nelson D, Ahluwalia JS. Mortality following operations for lower extremity peripheral arterial disease. Vasc Health Risk Manag. 2010;6:287–96. First citation in articleCrossref MedlineGoogle Scholar

  • 51 Ahmad N, Thomas GN, Gill P, Torella F. The prevalence of major lower limb amputation in the diabetic and non-diabetic population of England 2003–2013. Diab Vasc Dis Res. 2016;13:348–53. First citation in articleCrossref MedlineGoogle Scholar

  • 52 Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, Kragsterman B, Johansson S, et al. Editor’s choice – impact of comorbidity, medication, and gender on amputation rate following revascularisation for chronic limb threatening ischaemia. Eur J Vasc Endovasc Surg. 2018;56:681–88. First citation in articleCrossref MedlineGoogle Scholar

  • 53 Humphries MD, Brunson A, Li CS, Melnikow J, Romano PS. Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data. J Vasc Surg. 2016;64:1747–55. First citation in articleCrossref MedlineGoogle Scholar

  • 54 Humphries MD, Brunson A, Hedayati N, Romano P, Melnkow J. Amputation risk in patients with diabetes mellitus and peripheral artery disease using statewide data. Ann Vasc Surg. 2016;30:123–31. First citation in articleCrossref MedlineGoogle Scholar

  • 55 Newhall K, Spangler E, Dzebisashvili N, Goodman DC, Goodney P. Amputation rates for patients with diabetes and peripheral arterial disease: the effects of race and region. Ann Vasc Surg. 2016;30:292–8. First citation in articleCrossref MedlineGoogle Scholar

  • 56 Fosse S, Hartemann-Heurtier A, Jacqueminet S, Van Ha G, Grimaldi A, Fagot-Campagna A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med. 2009;26:391–6. First citation in articleCrossref MedlineGoogle Scholar

  • 57 Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30:964–72. First citation in articleCrossref MedlineGoogle Scholar

  • 58 Londero LS, Hoegh A, Houlind K, Lindholt J. Major Amputation Rates in Patients with Peripheral Arterial Disease Aged 50 Years and Over in Denmark during the period 1997–2014 and their Relationship with Demographics, Risk Factors, and Vascular Services. Eur J Vasc Endovasc Surg. 2019;58(5):729–37. First citation in articleCrossref MedlineGoogle Scholar

  • 59 Santosa F, Moysidis T, Kanya S, Babadagi-Hardt Z, Luther B, Kröger K. Decrease in major amputations in Germany. Int Wound J. 2015;12:276–9. First citation in articleCrossref MedlineGoogle Scholar

  • 60 Heyer K, Debus ES, Mayerhoff L, Augustin M. Prevalence and regional distribution of lower limb amputations from 2006 to 2012 in Germany: a population based study. Eur J Vasc Endovasc Surg. 2015;6:761–6. First citation in articleCrossrefGoogle Scholar

  • 61 Liang KW, Kuo HN, Lee WL, Liu TJ, Lin WW, Tsao CR, et al. Different mid-term prognostic predictors of major adverse events in diabetic and nondiabetic peripheral artery disease presenting with critical limb ischemia. Angiology. 2016;67:87–91. First citation in articleCrossrefGoogle Scholar

  • 62 Icks A, Scheerm M, Morbach S, Genz G, Haastert B, Giani G, et al. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation. Diabetes Care. 2011;34:1350–4. First citation in articleCrossref MedlineGoogle Scholar

  • 63 Müller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg. 2014;59:121–9. First citation in articleMedlineGoogle Scholar

  • 64 Müller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med. 2016;21:445–52. First citation in articleCrossref MedlineGoogle Scholar

  • 65 Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care. 2011;34:2244–9. First citation in articleCrossref MedlineGoogle Scholar

  • 66 Melillo E, Micheletti L, Nuti M, Dell′Omo G, Berchiolli R, Adami D, et al. Long-term clinical outcomes in critical limb ischemia – a retrospective study of 181 patients. Eur Rev Med Pharmacol Sci. 2016;20:502–8. First citation in articleMedlineGoogle Scholar

  • 67 Soyoye DO, Ikem RT, Kolawole BA, Oluwadiya KS, Bolarinwa RA, Adebayo OJ. Prevalence and correlates of peripheral arterial disease in Nigerians with diabetes. Advances in Medicine. 2016;1–6. First citation in articleCrossrefGoogle Scholar

  • 68 Mwebaze RM, Kibirige D. Peripheral arterial disease among adult diabetic patient attending a large outpatient diabetic clinic at a nation referral hospital in Uganda: a descriptive cross section study. PloS One. 2014;9:1–7. First citation in articleCrossrefGoogle Scholar

  • 69 Agrawal RP, Bishnoi P, Gothwal S, Sirohi P, Agrawal R. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. Journal of the Association of Physicians of India. 2014;62:44–8. First citation in articleGoogle Scholar

  • 70 Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms and outcomes. World J Diabetes. 2015;6(7):961–9. First citation in articleCrossref MedlineGoogle Scholar

  • 71 Cha JJ, Kim H, Ko YG, Choi D, Lee JH, Yoon CH, et al. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort. Cardiovasc Diabetol. 2020;19:97. https://doi.org/10.1186/s12933-020-01072-x First citation in articleCrossref MedlineGoogle Scholar

  • 72 Takahara M, Kaneto H, Iida O, Gorogawa S, Katakami N, Matsuoka TA, et al. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia. Diabetes Care. 2010;3312:2538–42. First citation in articleCrossrefGoogle Scholar

  • 73 Arya S, Binney ZO, Khakharia A, Long CA, Brewster LP, Wilson PW, et al. High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg. 2018;67(1):217–28. First citation in articleCrossref MedlineGoogle Scholar

  • 74 Aarabi G, Raedel M, Kreutzburg T, Hischke S, Debus ES, Marschall U, et al. Periodontal treatment and peripheral arterial disease severity – A retrospective analysis of health insurance claims data. VASA. 2020;49:128–32. First citation in articleLinkGoogle Scholar